Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
Jim Cramer says investors should remember the optionality of 6 of the Magnificent 7
CNBC’s Jim Cramer keyed in on the optionality of six of the companies that have become known as the “Magnificent Seven” during his Wednesday show. “The Magnificent Seven have the most optionality of any publicly traded companies in modern history,” Cramer said. “To sell any of them is to forget that they have this kind…
Customs union has not helped UK firms, economist says
Gerard Lyons tells CNBC there is too much fear about leaving the EU without a deal.
Jim Cramer recaps the year in generative artificial intelligence
CNBC’s Jim Cramer looked back on the year of artificial intelligence and highlighted some ways it has affected the world. “The good news? Generative AI can’t do everything,” Cramer said on his Thursday show. “The bad news? What it can do, it does better than we’ll ever do, unless maybe you’re Einstein or Beethoven or…
A lot of the negativity is already baked in to Alphabet’s stock, says Jefferies’ Brent Thill
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Nilay Patel, The Verge editor-in-chief, and Brent Thill, Jefferies analyst, join ‘TechCheck’ to discuss how the slowing digital advertising market is affecting employee treatment, what Thill is looking for from Alphabet earnings and more. 03:20 Tue, Jul 26 202212:09 PM EDT
Skylar Capital’s Bill Perkins calls Chesapeake & Southwestern possible merger ‘brilliant’
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Bill Perkins, Skylar Capital founder, and CNBC’s Pippa Stevens join ‘Power Lunch’ to discuss a possible merger between Chesapeake and Southwestern and natural gas outlook. 03:42 Wed, Jan 10 20242:59 PM EST
Trump will make a deal with Iran if he gets re-elected, DAMAC chairman says
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email But Hussain Sajwani, chairman of Middle Eastern property development firm DAMAC, says he doesn’t expect President Donald Trump to secure a deal in the Middle East this year. 02:11 Tue, Jan 21 20208:42 AM EST
